Identification of gamma-hydroxybutyrate (GHB)–β-ribose as a promising biomarker enabling prolonged detection of GHB intake

For several years, forensic toxicologists have sought biomarkers to extend the detection window of gamma-hydroxybutyric acid (GHB), a drug suspected to be involved in drug-facilitated sexual assaults yet difficult to detect due to its rapid elimination, endogenous presence, and postsampling formation. In this study, we used samples from 30 participants in a double-blind, controlled trial, randomized to placebo or a single oral dose (50 milligrams per kilogram) of sodium oxybate, a GHB salt. We collected whole blood and urine samples over 5 days and used untargeted metabolomics to search for biomarkers. The most promising feature, previously suggested as a GHB-pentose, was identified as GHB-β-ribose by chemical synthesis and liquid chromatography-tandem mass spectrometry. Quantification showed elevated levels of GHB-β-ribose for up to 48 in blood and 24 hours in urine after GHB intake compared with endogenous levels in the placebo group and authentic forensic cases. Thus, we present GHB-β-ribose as a very promising biomarker for GHB intake, with the potential to extend the detection window for GHB.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2026-11-13
DOI
https://doi.org/10.1126/sciadv.aeh1261
Primary Topic
Forensic Toxicology and Drug Analysis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Identification of gamma-hydroxybutyrate (GHB)–β-ribose as a promising biomarker enabling prolonged detection of GHB intake

Mogens Johannsen, Thomas Bjørnskov Poulsen, Camilla Bak Nielsen, Charlotte Uggerhøj Andersen et al.
3 links
Science Advances
Forensic Toxicology and Drug Analysis
article

Identification of gamma-hydroxybutyrate (GHB)–β-ribose as a promising biomarker enabling prolonged detection of GHB intake

Mogens Johannsen, Thomas Bjørnskov Poulsen, Camilla Bak Nielsen, Charlotte Uggerhøj Andersen, Søren Lau Borcher Møller, Kirstine Lykke Nielsen, Jørgen Bo Hasselstrøm, Lambert K. Sørensen, Kathrine Bohn Faldborg
article en

Abstract

For several years, forensic toxicologists have sought biomarkers to extend the detection window of gamma-hydroxybutyric acid (GHB), a drug suspected to be involved in drug-facilitated sexual assaults yet difficult to detect due to its rapid elimination, endogenous presence, and postsampling formation. In this study, we used samples from 30 participants in a double-blind, controlled trial, randomized to placebo or a single oral dose (50 milligrams per kilogram) of sodium oxybate, a GHB salt. We collected whole blood and urine samples over 5 days and used untargeted metabolomics to search for biomarkers. The most promising feature, previously suggested as a GHB-pentose, was identified as GHB-β-ribose by chemical synthesis and liquid chromatography-tandem mass spectrometry. Quantification showed elevated levels of GHB-β-ribose for up to 48 in blood and 24 hours in urine after GHB intake compared with endogenous levels in the placebo group and authentic forensic cases. Thus, we present GHB-β-ribose as a very promising biomarker for GHB intake, with the potential to extend the detection window for GHB.

Science AdvancesVol. 12(46)
Aarhus University (DK), Aarhus University Hospital (DK)
Aarhus Universitet
Good health and well-being
Forensic Toxicology and Drug Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon